Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Senior, M. After Glybera's withdrawal, what's next for gene therapy?. Nat Biotechnol 35, 491–492 (2017). https://doi.org/10.1038/nbt0617-491
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0617-491
- Springer Nature America, Inc.
This article is cited by
-
Selection of appropriate non-clinical animal models to ensure translatability of novel AAV-gene therapies to the clinic
Gene Therapy (2024)
-
Managing of Dyslipidaemia Characterized by Accumulation of Triglyceride-Rich Lipoproteins
Current Atherosclerosis Reports (2022)
-
The current landscape of nucleic acid therapeutics
Nature Nanotechnology (2021)
-
Individualized therapy trials: navigating patient care, research goals and ethics
Nature Medicine (2021)
-
Gene therapy: a double-edged sword with great powers
Molecular and Cellular Biochemistry (2020)